STATE OF WISCONSIN
Controlled Substances Board
IN THE MATTER OF RULE-MAKING
PROCEEDINGS BEFORE THE
CONTROLLED SUBSTANCES BOARD
ORDER OF THE
CONTROLLED SUBSTANCES BOARD
ADOPTING RULES
(CLEARINGHOUSE RULE 15-068)
ORDER
An order of the
Controlled Substances Board
to
create CSB
2.39
relating
to
exclusion of naloxegol.
Analysis prepared by the Department of
Safety and Professional Services
.
ANALYSIS
Statutes interpreted:
s.
961.
16
, Stats.
Explanation of agency authority:
If a substance is designated, rescheduled or deleted as a controlled substance under federal law and notice thereof is given to the controlled substances board, the board by affirmative action shall similarly treat the substance under this chapter after the expiration of 30 days from the date of publication in the federal register of a final order designating the substance as a controlled substance or rescheduling or deleting the substance or from the date of
issuance of an order of temporary scheduling under
21 USC 811
(h), unless within that 30−day period, the board or an interested party objects to the treatment of the substance. If no objection is made, the board shall promulgate, without making the determinations or findings required by subs. (1), (1m), (1r) and (2) or s.
961.13
,
961.15
,
961.17
,
961.19
or
961.21
, a final rule, for which notice of proposed rulemaking is omitted, designating, rescheduling, temporarily scheduling or deleting the substance. If an objection is made the board shall publish notice of receipt of the objection and the reasons for objection and afford all interested parties an opportunity to be heard. At the conclusion of the hearing, the board shall make a determination with respect to the treatment of the substance as provided in subs. (1), (1m), (1r) and (2) and shall publish its decision, which shall be final unless altered by statute. Upon publication of an objection to the treatment by the board, action by the board under this chapter is stayed until the board promulgates a rule under sub. (2).
[s.
961.11(4)
, Stats]
Related statute or rule:
n/a
Summary of, and comparison with, existing or proposed federal regulation:
On
January 23, 2015, the United States Department of Justice, Drug Enforcement Administration
published its final rule in the Federal Register
removing naloxegol from schedule II
of the federal Controlled Substances Act. The scheduling action was effective
January 23, 2015
.
Plain language analysis:
The Controlled Substances Board did not receive an objection to
excluding naloxegol
as a schedule I
I
under ch.
961
, Stats
.
based
upon the federal scheduling. The Controlled Substances Board took affirmative action on
March 25, 2015
to similarly
exclude naloxegol
under chapter 961 effective
April 1, 2015
to allow for publication in the Administrative Register. The Affirmative Action
Order
will expire upon promulgation of a final rule.
This rule
amends 961.16(2
)(
a)(intro)
, Stats.
which
excludes naloxegol from schedule II.
Comparison with rules in adjacent states:
Illinois
:
Illinois
does not exclude naloxegol from scheduling
.
Iowa
:
Iowa
does not exclude naloxegol from scheduling.
Michigan
:
Michigan
does not exclude naloxegol from scheduling.
Minnesota:
Minnesota
has a bill to exclude naloxegol from scheduling.
Summary of factual data and analytical methodologies:
The methodology was to
remove naloxegol from scheduling
to conform
with
the federal Controlled Substances Act.
Analysis and supporting documents used to determine effect on small business or in preparation of economic impact
analysis
:
This rule was posted for 14 days for economic comments and none were received.
Fiscal Estimate and Economic Impact Analysis:
The Fiscal Estimate and Economic Impact Analysis is attached.
Effect on small business
:
These proposed rules
do
not
have
an economic impact on small businesses, as defined in s.
227.114 (1)
, Stats. The Department’s Regulatory Review Coordinator may be contacted by email at
Jeff.Weigand
@wisconsin.gov
, or by calling (608)
267-2435
.
Agency contact person
:
Sharon
Henes
, Administrative Rules Coordinator
, Department of
Safety and Professional Services
, Division of Board Services, 1400 East Washington Avenue, Room 151, P.O. Box
8366
, Madison, Wisconsin 53708; telephone 608-
261-2377
; email at
Sharon.Henes
@wisconsin.gov
.
TEXT OF RULE
Section
1. CSB 2.3
9
is created to read:
961.16(2
)(
a)(intro)
Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, nalbuphine, butorphanol, nalmefene,
naloxegol,
naloxone and naltrexone and their respective salts and the isoquinoline alkaloids of opium and their respective salts are excluded from this paragraph. The following substances, and any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
Section
2
. EFFECTIVE DATE.
The rules adopted in this order shall take effect on the first day of the month following publication in the
Wisconsin
administrative register, pursuant to s.
227.22 (2) (intro.)
, Stats.
---------------------------------------------------------------------------------------------------------------------
(END OF TEXT OF RULE)
---------------------------------------------------------------------------------------------------------------------
